2008 Tenofovir/Emtricitabine/Efavirenz vs. Zidovudine/Lamivudine + Efavirenz... Initiation of Antiretroviral Therapy at CD4 Cell Counts... 2007 Randomized Study of Poly-L-Lactic Acid for HIV Facial Lipoatrophy... Directly Administered Antiretroviral Therapy (DAART)... Routine HIV Screening in the Emergency Department... IRIS: Risk Factors and Treatment Implications... FRAM Study: Upper Trunk and Visceral Adipose Tissue in HIV... Magnetic Resonance Spectroscopy of Hepatic Lipid Content... Integrase Inhibitor Raltegravir Has Rapid and Durable Antiretroviral Effect... How Homosexual Men Believe They Became Infected With HIV... Adults With CD4 >500 on HAART -- Same Mortality Rates as General Population... Safety and Efficacy of Darunavir (TMC114) With Low-Dose Ritonavir... Comparing Initial HAART Response in US and Brazil... Long-Term Body Fat Outcomes in Antiretroviral-Naive Participants... The Relation Between Symptoms, Viral Load (VL), and Viral Set Point... 80-Week Data From a Phase 2 Study... A Microchip Approach for Practical Label-Free CD4+ T-Cell Counting... Recombinant Human Growth Hormone to Treat HARS... CD4 Cell Counts of 800 Cells/mm3 Feasable After 7 Years of HAART... Editorial: When To Initiate HIV ART Therapy... Prospective Screening for HLA-B*5701 Avoids Abacavir Hypersensitivity... The Relationship Between Methamphetamine and Popper Use... Long-Term Body Composition and Metabolic Changes in ART Naive Persons... Metabolic Effects of Protease Inhibitor-Sparing ART Regimens Given for HIV... Early Virologic Rebound in a Pilot Trial of Ritonavir-Boosted Atazanavir... Two and a Half Years of Routine HIV Testing in Botswana... Pretreatment Factors With 3-Year Virologic and Immunologic Responses to ART... Occult Hepatitis B Virus in a Prospective Cohort of HIV-Infected Patients... Predictive Value of Early Virologic Response in HIV/Hepatitis C Coinfection... Effects of a Behavioral Intervention to Reduce Risk of HIV Transmission... Characteristics of Persons With Recently Acquired HIV Infection... Predictors of Antiretroviral Treatment Failure in an Urban HIV Clinic... 2006 Antiretroviral Activity, Pharmacokinetics, and Tolerability of MK-0518... Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz ... Hazardous Alcohol Use: A Risk Factor for Non-Adherence in HIV Infection... 1-Year Outcomes of Infective Endocarditis in an Urban HIV Cohort... Measuring the Outcomes of a Comprehensive HIV Care Course... Pharmacokinetics and Safety of Tenofovir Disoproxil Fumarate... Occurrence of Vaginal Infections Among HIV-Infected and High-Risk Women... Disadvantages of Structured Treatment With Multidrug-Resistant HIV... Antiviral Activity, Pharmacokinetics, and Dose Response of GS-9137... Mortality in the Highly Active Antiretroviral Therapy Era... Micronutrient Supplementation Increases CD4 Count in HIV-Infected People... Fat Distribution in Women With HIV Infection... Effect of Baseline- and Treatment-Related Factors on Immunologic Recovery ... Antiretrovirals Induce Direct Endothelial Dysfunction in Vivo... Osteonecrosis in Patients Infected With HIV... Highly Active Antiretroviral Therapy... Evaluating T-cell Count After Treatment Interruption... Nucleoside Activity and HIV Prevention in Infants... Drug Resistance & Efficacy of First-Line Antiretroviral Therapy... Pharmacologic Optimization of Protease Inhibitors and POPIN... Prevalence of Transmitted Antiretroviral Drug-Resistant HIV-1... Nonadherence to Antiretroviral Therapy in HIV-Infected Patients... Bioequivalence of Nevirapine, Zidovudine, and Lamivudine... Diagnosis of Hepatic Fibrosis and Cirrhosis ... Acute Hepatitis C Infection in HIV-Infected Patients... Reducing Unprotected Sexual Behavior Among HIV-Infected Patients... 2005 Prednisolone Pharmacokinetics... Infection Does Not Affect the Performance of Noninvasive Markers... Safety of Enfuvirtide in Combination With Antiretrovirals... Efficacy of Enfuvirtide in Treatment-Experienced HIV-1 Patients... Discordant Immunologic and Virologic Responses to Therapy... Lopinavir/Ritonavir as Single-Drug Therapy for Maintenance... Herpes Zoster Among HIV Patients in Antiretroviral Therapy Era... Protease Inhibitor Use in 233 Pregnancies... HIV-1 Drug Resistance Among Patients on Potent Combo of ART... Race, Sociodemographics, Behavior - HAART in Women... HAART Retreatment in CD4-Guided Therapy vs. Continous HAART... ... Cervical Intraepithelial Neoplasia - Women With HIV... Results of AIDS Clinical Trials Group 5108 Study... Induction With Abacavir/Lamivudine/Zidovudine Plus Efavirenz ... Incidence of Pancreatitis in HIV-1-Infected Individuals Enrolled... Intermittent Low-Level Viremia in Very Early Primary HIV-1... Nonnucleoside Reverse Transcriptase Inhibitor Phenotypic... Increased Dose of Lopinavir/Ritonavir Compensates for... Long-Term Neuropsychiatric Disorders on Efavirenz-Based Approach... Use of the Serologic Testing Algorithm for Recent HIV... ... Abacavir Once or Twice Daily Combined With Once-Daily Lamivudine... Persistence of Nevirapine Exposure During the Postpartum Period ... ... Outcomes of Offering Rapid Point-of-Care HIV Testing in A ... Risk Factors for In Utero and Intrapartum Transmission of HIV... Diabetes, Insulin Resistance, and Dementia Among HIV-1-Infected ... 2004 Selection of Antiretroviral Therapy Guided by Genotypic or... HIV-Associated Anal Cancer: Has Highly Active Antiretroviral... Renal Dysfunction With Tenofovir-Containing Highly Active... Case-Control Study of Diabetes Mellitus in HIV-Infected Patients... Patterns of Resistance Emerging in HIV-1 From... ... Progressive Multifocal Leukencephalopathy in Patients on Highly ... ... Effect of Persistent Moderate Viremia on Disease Progression Dur... Absolute CD4 Vs. CD4 Percentage for Predicting the Risk of... Comparison of Once-Daily Atazanavir With Efavirenz, Each in... Comparison of Once-Daily Atazanavir With Efavirenz, Each in ... HIV Transmission Risk Behavior Among Men and Women Living With... Perspectives on Adherence and Simplicity for HIV-Infected... Maternal Toxicity With Continuous Nevirapine in Pregnancy:... Changes in Total Lymphocyte Count as a Surrogate for Changes in ... Highly Active Antiretroviral Therapy Improves Neurocognitive ... Efavirenz Versus Nevirapine in Current Clinical Practice... Herpes Simplex Virus-2 and HIV-1 Acquisition/Transmission... Correlates of National HIV Seroprevalence: An Ecologic Analysis... Comparison of Drug Resistance Mutations... Impact of Adherence on CD4 Cell Count Among HIV-Infected... Renal Tubular Dysfunction Associated With Tenofovir Therapy... Transport of HIV Protease Inhibitors Through the Blood-Brain... Comparative Therapy for HIV-Positive Patients With Candidiasis... Nevirapine Resistance Mutations in Women... The NEAT Study... Differences in HIV Disease Progression by Injecting Drug Use... 2003 Selective Neuronal Damage in Methamphetamine-User AIDS Patients... HIV-1 Antiretroviral-Treated Patients With Viral Suppression... Once-Weekly Epoetin Alfa Dosing in Anemix HIV Patients... Grade 4 Events as Important as AIDS Events in the Era of HAART... Low Rate of Mother-to-Child Transmission of HIV-1... Perinatal HIV Prevention: What Do We Really Know?... Changes in HIV-Related Preventive Behavior in the US Population... Pharmacokinetics of Indinavir/Ritonavir... Mitochondrial Dysfunction in HIV-Infected People... Modeling the Time Course of CD4 T-Lymphocyte Counts... An Objective Lipodystrophy Severity Grading Scale... Lopinavir Plasma Concentrations and Changes in Lipid Levels Duri... HIV-1 Infection and Maturation of Myeloid Dendritic Cells... Coronary Heart Disease in HIV-Infected Individuals... The Impact of Hepatitis C Virus Coinfection on HIV Progression... Urban HIV-1 Clinics in the Era of Active Antiretroviral Therapy ... Pretreatment of Chronic Active Hepatitis C... Incomplete CD4 T Cell Recovery in HIV-1 Infection... Extended Treatment With Tenofovir Disoproxil Fumarate... Rapid Communication: HIV-1 Protease and Reverse Transcriptase ... Comparison of Two Strategies for Administering Nevirapine in HIV... Toxicity and the Concurrent Use of Lopinavir/Ritonavir... Pharmacokinetics of Once-Daily Saquinavir ... Antiretroviral Therapy and Persistence of HIV RNA in Semen ... Severe Hepatotoxicity with Combination Antiretroviral Treatment... Protease Inhibitor-Associated Diabetes Mellitus... Lopinavir in Individuals Experiencing Protease Inhibitor Failure... Once-Daily Saquinavir-sgc Plus Low-Dose Ritonavir ... One Year of Highly Active Antiretroviral Therapy ... Results of a Phase Two Clinical Trial at 48 Weeks... | 
